Global strategies to reverse the rise of liver cancer

Liver cancer is the sixth most common cancer and the third leading cause of cancer-related mortality globally. The number of new liver cancer cases will nearly double, from 0.87 million in 2022 to 1.52 million in 2050, if there is no change in the current trend. This Lancet Webinar covers: An overview of The Lancet Commission on addressing the global HCC burden and its comprehensive strategies from prevention to treatment. How the global community is tackling the rising trend of liver cancer. The differences in liver cancer epidemiology and management across different regions. The emerging threat of metabolic dysfunction-associated steatotic liver diseases (MASH) and its implications. Visit The Lancet Group at https://www.thelancet.com?dgcid=youtu... * * Continue this conversation on social! Follow us today at… https://TheLancet.bsky.social/   / thelancetmedicaljournal     / thelancetgroup     / the-lancet